Suppl. Figure 1 A B Suppl. Figure 1. Relative (A) miR-21 and (B) miR-224 expression levels in HCC tumors in different stages (I,II,III,IV) assessed by.

Slides:

Advertisements

Similar presentations

Suppl. Figure 1 miR-107 levels NormalPituitary Tumors miR-103 levels miR-125b levels miR-141 levels miR-144 levels miR-164 levels miR-145 levels miR-143.

Advertisements

NEGpre-221 pre-222pre-221/222 NEG DMSO 100 nM Fulvestrant for 72h Figure S1. Cell morphology of MCF7 cells after treatment with fulvestrant, with or without.

AB C Breast cancer Gas6 RNA Seq D E F Figure S1. AXL and GAS6 expression correlates with a mesenchymal signature. (A) Scatter plot representing the RNA.

C. HENDRICKS, L. JANSSEN, R. DELCOMBEL, J. DUBAIL, C. DEROANNE, A. COLIGE Laboratory of Connective Tissues Biology, GIGA-Cancer, University of Liège, Tour.

Jingfu wang The role of WT1 gene in neuroblastoma Department of Pediatric Oncology Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin.

Figure S1. RNA-seq results for caveolin-1 (Cav1). Upper panel: UCSC genome browser view. Lower panel: quantification o f Cav1 expression based on RNA-seq.

Supporting Figure 1: Acute leptin and IL-6 treatments on pY-STAT3 phosphorylation in HuH7 cells. A) HuH7 cells were transfected with pcDNA3-LepRb and empty.

WT KO A B Suppl. Fig 1 Supplemental Figure 1. The expression of CYLD in liver. (A) Immunohistochemical analysis of CYLD in liver tissue of adult wildtype.

- KLF6 869 bp IHH HepG2 Hep3B HuH bp- 800 bp- 700 bp- 600 bp- SV1 715 bp SV2 743 bp SV3 745 bp IHH HepG2 Hep3B HuH Percentage of.

Marker (%) Normal EPCs Mean ± SM (%) MMD EPCs Mean ± SM (%) CD ± ± 6.8 KDR27.3 ± ± 8.90 CD ± ± 3.93 CD ±

-33 Red bar: tonsil tumour samples, n =14 x2 Green bar: tonsil normal samples, n = 9 x2 A B Supplementary Figure 1. A)Unsupervised HCL analysis was used.

Supplementary Fig. 1. RT-PCR showed that tumor tissues have elevated Mst1 mRNA levels in most of the HCC patients tested. GAPDH RT-PCR products were shown.

Supplementary Figure 1 Supplementary Figure 1. Representative micrographs of migration and invasion assays. miR-452 or si-WWP1 transfectants inhibited.

Products > U87 Transfection Reagent (Glioblastoma Cells) Altogen Biosystems offers the U87 Transfection Reagent among a host of 100+ cell line specific.

Products > PC-3 Transfection Reagent (Prostate Cancer Cells) Altogen Biosystems offers the PC-3 Transfection Reagent among a host of 100+ cell line specific.

Altogen Biosystems offers the 786-O Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection Kits. 786-O Transfection Reagent.

Supplementary Figure S4

Volume 342, Issue 1, Pages (January 2014)

From: Lentiviral Vector-Mediated PAX6 Overexpression Promotes Growth and Inhibits Apoptosis of Human Retinoblastoma Cells Invest. Ophthalmol. Vis. Sci..

Volume 141, Issue 5, Pages e1 (November 2011)

Figure S1. qPCR analysis of the EMT markers ZEB2 and SNAI1 in Syndecan-1 and control siRNA transfected MDA-MB-231 and MCF-7 cells reveals no significant.

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.

KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate- Specific Antigen-Relapse Following Radical Prostatectomy Johannes Stein,

Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small.

The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR) Cell.

Cell Physiol Biochem 2017;44:1867– DOI: /

Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.

a b c ** ** ** ** * * * P450arom mRNA Trascript Levels (Fold)

miR-133a positively regulated p53/p21 pathway.

Volume 143, Issue 3, Pages e15 (September 2012)

Volume 133, Issue 2, Pages (August 2007)

Supplementary figure S1 by Shin et al.

MicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7 Yixiong Lin, Jianjun Liu, Yuqi Huang,

Volume 141, Issue 5, Pages e1 (November 2011)

Chandra M.V. Goparaju, PhD Journal of Thoracic Oncology

Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity Jing Xue, Xuebing Li, Shi Jiao,

Volume 39, Issue 4, Pages (August 2010)

Volume 17, Issue 4, Pages (April 2010)

Volume 136, Issue 2, Pages (February 2009)

Cysteine cathepsins (proteases)—On the main stage of cancer?

Yuen Yee Cheng, PhD, Michaela B

Volume 130, Issue 3, Pages (September 2013)

Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.

Volume 17, Issue 4, Pages (April 2010)

Molecular Therapy - Nucleic Acids

Volume 44, Issue 1, Pages (January 2006)

MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2 Ji-guang Zhang,

Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma Hui-Ju Wen, Michael.

Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk Xinyu Yang, Dianke Yu, Yanli Ren, Jinyu Wei, Wenting.

Fig. 3. miR-370 overexpression suppressed cell migration and invasion in HCC cells. (A) miR-370 expression in miR-370 overexpressed HCCLM3 cells were detected.

Thymidylate synthase as an oncogene

Fig. 1. miR-370 was downregulated, and GUCD1 was upregulated in HCC

Fig. 6. Alteration of GUCD1 expression partially reversed the miR-370-mediated effect on HCC cell migration and invasion. (A) Western blot (up) and qRT-PCR.

Volume 147, Issue 6, Pages (December 2011)

Fold Change of hsa-miR-3687 (T/N)(log2)

The ERK pathway mediates the effect of EGF on LIMT, which normally inhibits mammary cell migration and invasion The ERK pathway mediates the effect of.

Supplementary Fig. S1 BCL2 5’flanking ctrl siRNA luc

An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation Dimitrios Iliopoulos, Heather A. Hirsch,

Supplemental Figure 1 Cell proliferation (% of mock)

The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI Feng Xing, Shuo Wang, Jianhong Zhou Molecular.

Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis. Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis.

Overexpression of L1 in CRC cells induces NF-κB activation and suppression of p65 expression blocks the capacity to confer liver metastasis. Overexpression.

IGF-IR in human head and neck cancer.

Effect of miRNA mimic on platinum sensitivity.

miR-100 suppresses bladder cancer cell growth in vitro and in vivo.

HOXA11-AS acts as a ceRNA for miR-1297.

Decreased dopamine uptake following downregulation of SLC6A3.

Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar. Depleting NQO1 expression levels inhibits growth of NSCLC cells in soft agar.

Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.

MYC is required for the hypoxic induction of SHMT2.

Presentation transcript:

Suppl. Figure 1 A B Suppl. Figure 1. Relative (A) miR-21 and (B) miR-224 expression levels in HCC tumors in different stages (I,II,III,IV) assessed by real-time RT-PCR analysis and normalized to control liver tissues. Data are represented as mean ± SE. ***P<0.001, in comparison to control.

Suppl. Figure 2 ABCD Suppl. Figure 2. Effects of miR-9 overexpression on HepG2 cancer properties. (A) Relative miR-9 expression levels in HepG2 cells after transfection with miR control or miR-9, 48h post-transfection. (B) Cell growth of HepG2 liver cancer cells transfected with miR negative control (miR-Ctrl) or miR-9, 48h and 72h post-transfection. (C) Invasion of HepG2 after transfection with miR negative control (miR-Ctrl) or miR-9, 48h post-transfection. (D) Soft agar colony assay in HepG2 cells overexpressing miR negative control (miR-Ctrl) or miR-9. All data are represented as mean ± SE. ***P<0.001, **P<0.01.

Suppl. Figure 3 Suppl. Figure 3. PPARA relative mRNA levels after CDH1 inhibition in SNU-449 cells. PPARA mRNA levels were measured by qPCR analysis in SNU-449 cells transfected with an siRNA negative control (si-NC) and an siRNA against CDH1 (si-CDH1), 48h post-transfection. si-NC si-CDH1